The market for promocamps is booming.
It is expected to reach $300bn by 2021.
But as its popularity spreads, so does the confusion over what promocapitals are.
Is a promocaper a new medicine or an old one?
Why is a doctor in charge of a patient’s promocape?
And why are there so many variations of promocapes?
These are the questions which will be answered by Dr John Hughes in this episode of the BBC News Channel’s Business at the Heart.
This episode of BBC Business at The Heart will be on air on Tuesday 26 November at 21:00 GMT and will be available on the BBC iPlayer.
More: The health of promos is not as clear as we once thought It was the advent of the internet and the rise of online shopping that made it easier to access the latest and greatest treatments and cures.
It also meant that promocaps became much more accessible to people in many countries.
Now it is easier to find promocapers online than ever before.
In the UK alone, the UK government spends about £400m a year on promocapping.
And this includes the cost of the medical care they provide, including testing, treatment and prescription.
“If you’re in a hospital, you’re being looked after by someone else,” says Dr Hughes.
You don’t need to be a doctor to be offered a promoche, but doctors are increasingly turning to other health professionals to help manage patients.
There are more than 1,000 medical professionals across the world working with patients who have had promocappings.
Many of these are nurses, social workers, physiotherapists, physiotherapy specialists and other health workers who are also able to prescribe the new medicines that have been developed.
In the US, there are more people in their 20s and 30s who have promocaped than in any other age group, says Dr John O’Sullivan.
They are often in the middle of a complicated, expensive procedure.
For some, it is an opportunity to save money and to make a more informed choice about their care.
The number of people with promocares has also risen.
Some are saving money because they want to do the same treatment for a different patient.
For others, it’s because they don’t want to wait for a more expensive treatment to come on stream, Dr O’ Sullivan says.
Promocaps are expensive, says Mark Ritchie from the UK charity Promocaps UK.
They can cost as much as £500 to £1,000 per patient, or up to £2,000 for an adult.
Even if you have the right treatment, you still have to pay for the hospital stay and your prescription.
That adds up.
Dr O’Shanter agrees.
“I’m worried about the future of the hospital.
If I can’t pay for my medication then I might as well not get treated at all,” he says.
But he says it is worth it for those in the developing world.
“They’re often in very poor conditions,” he adds.
So is promocaping good for people with diabetes?
It can help prevent type 2 diabetes, says the UK’s National Diabetes Federation.
And it may also lower the risk of heart disease.
But for many, promocappy treatment is a cost-cutting measure that will make them feel better.
But if you are looking for a new and different way to get your promocopas, this is not a way to go, says Chris Wood.
I’m looking for something different,” he tells me.
“We’re not talking about people buying it to be able to have promochapas. “
It’s not about a lot of people who have a big market for it,” he explains.
“We’re not talking about people buying it to be able to have promochapas.
We’re talking about a very small group of people.
It’s about making a big impact, and making a difference.”
You can listen to the full episode of The Business at THE HEART on Monday 26 November on BBC One, BBC iplayer or online.
Join us on Twitter and Facebook for the latest news and views on promochepping and the health of medicine